DXL

Welcome to the Brand page for “DXL”, which is offered here for Research, development services in the field of immunotherapeutic substances; clinical testing; medical therapy and immunotherapy; patient monitoring and treatment; immunodiagnostic services and monitoring thereof; and consultation provided in connection therewith;.

Its status is currently believed to be active. Its class is unavailable. “DXL” is believed to be currently owned by “InNexus Biotechnology International Ltd.”


Owner:
INNEXUS BIOTECHNOLOGY INTERNATIONAL LTD.
Owner Details
Description:
Research, development services in the field of immunotherapeutic substances; clinical testing; medical therapy and immunotherapy; patient monitoring and treatment; immunodiagnostic services and monitoring thereof; and consultation provided in connection therewith;
Categories: RESEARCH